These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 18270495

  • 21. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S, Loof T, Martini S, Rückert M, Wang Y, Böhler T, Shimizu F, Kawachi H, Neumayer HH, Peters H.
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Glomerular expression of neuronal activity-regulated pentraxin precedes the development of anti-Thy-1-induced progressive glomerulosclerosis.
    Aben JA, Ijpelaar DH, Baelde H, Worley P, Noble N, Bruijn JA, de Heer E.
    Kidney Int; 2006 Oct; 70(7):1279-86. PubMed ID: 16900090
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Effects of TJN-598, a new selective phosphodiesterase type IV inhibitor on anti-Thy1 nephritis in rats.
    Sadakane C, Kase Y, Koseki J, Hasegawa Y, Shindo S, Maruyama H, Takeda S, Takeda H, Hattori T.
    Clin Exp Nephrol; 2011 Feb; 15(1):14-24. PubMed ID: 20820840
    [Abstract] [Full Text] [Related]

  • 28. Multi-glycoside of Tripterygium wilfordii Hook f. ameliorates proteinuria and acute mesangial injury induced by anti-Thy1.1 monoclonal antibody.
    Wan Y, Gu L, Suzuki K, Karasawa T, Fujioka Y, Han GD, Koike H, Kawachi H, Shimizu F.
    Nephron Exp Nephrol; 2005 Feb; 99(4):e121-9. PubMed ID: 15722645
    [Abstract] [Full Text] [Related]

  • 29. Effect of antiproteolytic drugs: epsilon-aminocaproic acid (EACA) and aprotinin on experimental anti-GBM nephritis.
    Hruby Z, Wendycz D, Kopeć W, Czerchawski L, Józefowiak M, Rabczyński J.
    Nephrol Dial Transplant; 1996 Jan; 11(1):32-9. PubMed ID: 8649650
    [Abstract] [Full Text] [Related]

  • 30. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis.
    Peters H, Martini S, Woydt R, Rückert M, Shimizu F, Kawachi H, Liefeldt L, Krämer S, Neumayer HH.
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1105-14. PubMed ID: 12676738
    [Abstract] [Full Text] [Related]

  • 31. Platelet inhibition limits TGF-beta overexpression and matrix expansion after induction of anti-thy1 glomerulonephritis.
    Peters H, Eisenberg R, Daig U, Liefeldt L, Westenfeld R, Gaedeke J, Krämer S, Neumayer HH.
    Kidney Int; 2004 Jun; 65(6):2238-48. PubMed ID: 15149337
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C, Corna D, Rottoli D, Cattaneo D, Zanchi C, Tomasoni S, Abbate M, Remuzzi G.
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [Abstract] [Full Text] [Related]

  • 34. In vivo effect of OPC15161, a superoxide scavenger, on anti-Thy1 nephritis.
    Hamada N, Nagase M.
    Eur J Pharmacol; 1996 Dec 12; 317(1):123-8. PubMed ID: 8982728
    [Abstract] [Full Text] [Related]

  • 35. P2 receptor antagonist PPADS inhibits mesangial cell proliferation in experimental mesangial proliferative glomerulonephritis.
    Rost S, Daniel C, Schulze-Lohoff E, Bäumert HG, Lambrecht G, Hugo C.
    Kidney Int; 2002 Nov 12; 62(5):1659-71. PubMed ID: 12371966
    [Abstract] [Full Text] [Related]

  • 36. Mesenchymal stromal cells improve renal injury in anti-Thy 1 nephritis by modulating inflammatory cytokines and scatter factors.
    Rampino T, Gregorini M, Bedino G, Piotti G, Gabanti E, Ibatici A, Sessarego N, Piacenza C, Balenzano CT, Esposito P, Bosio F, Soccio G, Frassoni F, Dal Canton A.
    Clin Sci (Lond); 2011 Jan 12; 120(1):25-36. PubMed ID: 20583996
    [Abstract] [Full Text] [Related]

  • 37. Inhibition of matrix metalloproteinases attenuates anti-Thy1.1 nephritis.
    Steinmann-Niggli K, Ziswiler R, Küng M, Marti HP.
    J Am Soc Nephrol; 1998 Mar 12; 9(3):397-407. PubMed ID: 9513901
    [Abstract] [Full Text] [Related]

  • 38. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C, Corna D, Bruzzi I, Foglieni C, Bertani T, Remuzzi G, Benigni A.
    Exp Nephrol; 1996 Mar 12; 4(4):213-21. PubMed ID: 8983642
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis.
    Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen G, Yu D, Floege J.
    J Am Soc Nephrol; 2006 Aug 12; 17(8):2202-12. PubMed ID: 16790513
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.